We analyzed CD3-epsilon−/− mice for tumor growth following transplantation of 105 GFP+ TBL (Triple-Transgenic B cell Lymphoma) lymphoma cells, which are derived from an E-mu-MYC/BCRHEL/sHEL transgenic mouse [16], [17]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.